How to start an adrenaline infusion in a critically ill adult with hypotension unresponsive to noradrenaline and vasopressin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Adrenaline Infusion in Refractory Hypotension

When hypotension persists despite noradrenaline and vasopressin, commence an adrenaline (epinephrine) infusion at 0.05-0.1 mcg/kg/min peripherally while preparing for central access, and escalate by doubling the dose every 10 minutes if inadequate response. 1

Pre-Infusion Requirements

Before initiating adrenaline, ensure the following baseline management is optimized:

  • Confirm adequate fluid resuscitation with at least 30 mL/kg crystalloid bolus, as inadequate volume loading will worsen organ hypoperfusion despite vasopressor support 2, 3
  • Verify noradrenaline dosing has reached 0.25 mcg/kg/min (approximately 15-20 mcg/min in a 70 kg adult) before adding adrenaline 2
  • Confirm vasopressin is running at 0.03-0.04 units/min, as this is the maximum recommended dose before adding additional agents 1, 2
  • Establish arterial line monitoring for continuous blood pressure assessment, as frequent titration will be required 2, 3

Adrenaline Infusion Protocol

Initial Preparation and Dosing

  • Standard concentration: Add 4 mg adrenaline to 250 mL D5W to create 16 mcg/mL solution 3
  • Starting dose: 0.05-0.1 mcg/kg/min (3.5-7 mcg/min in a 70 kg adult) via continuous IV infusion 1, 2
  • Administration route: Peripheral IV access is acceptable initially while preparing central access, as delays in vasopressor administration worsen outcomes 1

Titration Strategy

  • Monitor blood pressure every 5-15 minutes during initial titration 3
  • Target MAP ≥65 mmHg while assessing tissue perfusion markers (lactate clearance, urine output, mental status, capillary refill) 2, 3
  • Escalate by doubling the bolus dose every 10 minutes if inadequate sustained response 1
  • Maximum practical dose: 0.5-2 mcg/kg/min, though higher doses may be required in refractory shock 2, 3

Critical Monitoring Requirements

Hemodynamic Parameters

  • Continuous arterial pressure monitoring is mandatory once adrenaline is initiated 2, 3
  • Assess tissue perfusion beyond MAP: lactate trends, urine output >0.5 mL/kg/h, mental status, skin perfusion 2
  • Monitor for excessive vasoconstriction: cold extremities, rising lactate despite adequate MAP, decreasing urine output 2

Cardiac Monitoring

  • Watch for tachyarrhythmias, as adrenaline significantly increases this risk (RR 0.35 for ventricular arrhythmias when used early) 2
  • Monitor for myocardial ischemia, particularly in patients with coronary disease, as adrenaline increases myocardial oxygen consumption more than noradrenaline 2
  • Expect transient lactic acidosis from β2-adrenergic stimulation of skeletal muscle, which interferes with lactate clearance as a resuscitation endpoint 2

Adjunctive Therapies to Consider

When Myocardial Dysfunction is Present

  • Add dobutamine 2.5-20 mcg/kg/min if persistent hypoperfusion exists despite adequate MAP and vasopressor therapy, particularly when echocardiography demonstrates reduced contractility 1, 2
  • Start low (2.5 mcg/kg/min) and double every 15 minutes according to response, with dose usually limited by tachycardia or arrhythmias 2

For Refractory Shock

  • Consider hydrocortisone 200 mg/day IV for shock reversal if hypotension remains refractory, as corticosteroids have decreased 28-day mortality in some large trials 2
  • Evaluate for extracorporeal life support if available and patient is a candidate 1

Common Pitfalls and How to Avoid Them

Dosing Errors

  • Never escalate vasopressin above 0.03-0.04 units/min before adding adrenaline, as higher vasopressin doses cause cardiac, digital, and splanchnic ischemia without mortality benefit 1, 2
  • Do not use dopamine as an alternative, as it is associated with higher mortality and more arrhythmias compared to noradrenaline 2, 4
  • Avoid phenylephrine in this scenario, as pure alpha-agonism may raise blood pressure numbers while actually worsening tissue perfusion 2

Volume Status Mistakes

  • Never start adrenaline in hypovolemic patients, as vasoconstriction without adequate preload causes severe organ hypoperfusion despite "normal" blood pressure 2, 3
  • Reassess volume status if adrenaline requirements rapidly escalate, as ongoing fluid losses may be present 2

Monitoring Gaps

  • Do not rely solely on MAP targets—patients may have adequate blood pressure but poor tissue perfusion 2
  • Trend lactate every 2-4 hours initially, recognizing that adrenaline causes transient elevation through β2-stimulation 2
  • Watch for digital ischemia with high-dose catecholamines, particularly when combined with vasopressin 1, 2

Special Considerations

In Anaphylaxis Context

  • Use higher initial bolus doses (50-200 mcg IV) rather than starting an infusion if anaphylaxis is the underlying cause 1
  • Commence infusion at 0.05-0.1 mcg/kg/min only after more than three adrenaline boluses have been administered 1

In Septic Shock

  • Adrenaline is the recommended second-line agent when noradrenaline plus vasopressin fail to achieve target MAP 2, 4
  • Early administration may improve cardiac output through increased preload and contractility, even in patients with poor baseline cardiac function 5

Transition to Central Access

  • Plan for central line placement as soon as practical, though peripheral administration is acceptable initially 1, 3
  • If extravasation occurs, infiltrate phentolamine 5-10 mg diluted in 10-15 mL saline at the site immediately 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.